Full-Service CRO for Ophthalmology Clinical Trials

Genetic, rare, age-related and degenerative ophthalmic diseases currently affect an estimated 285 million people globally. An aging global population has created increased interest and opportunity in developing new ocular disease treatments. Ophthalmology clinical studies are highly specialized, requiring intimate knowledge of trial and indication experience, strong relationships with quality research sites as well as technical skills.

As a global, full-service CRO, Worldwide Clinical Trials will work with you to maximize efficiency and value for your ophthalmology clinical study—from all phases of trial design to commercialization and beyond.